[150] In November 2025, the United States President Donald Trump announced a deal with NovoNordisk to lower the costs of Ozempic, including monthly prices of about $245 for injectables and $149 for some oral versions for people on Medicare and Medicaid and for those who use his TrumpRx platform
Tyna Moore In this episode, Dr
As this was the first research of its kind to report a link between NAION and semaglutide use, the study authors concluded that it did not establish a causal relationship between the two. Thus, they recommended future investigation into this association should involve one of the following: Larger, retrospective, multicenter, population-based study Prospective, randomized clinical trial (RCT) Post-market analysis of all GLP-1 RA drugs
Medicare typically covers semaglutide only for type 2 diabetes
The tramadol intake in Group B was significantly lower than in Group A (P=0.021)